Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS

Authors

• Dustin B Hammers, Indiana University
• Kyle Womack, Washington University School of Medicine in St. Louis
• Erik Musiek, Washington University School of Medicine in St. Louis
• et al.

Journal

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Publication Date

1-1-2026

Volume

18

Issue

2

First Page

e70342

Document Type

Open Access Publication

DOI

10.1002/dad2.70342

Rights and Permissions

Hammers DB, Polsinelli A, Eloyan A, et al. Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS. Alzheimer's Dement. 2026; 18:e70342. https://doi.org/10.1002/dad2.70342 © 2026 The Author(s). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Recommended Citation

Hammers, Dustin B; Womack, Kyle; Musiek, Erik; and et al., "Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS." Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 18, 2. e70342 (2026).
https://digitalcommons.wustl.edu/oa_4/7255

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.